Lipella Pharmaceuticals Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Lipella Pharmaceuticals Inc. (LIPO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-11-14
- Lipella Pharmaceuticals Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Lipella Pharmaceuticals Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $6.16.
- Lipella Pharmaceuticals Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $17.52, a 250.40% increase from fiscal 2022.
- Lipella Pharmaceuticals Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $5.00, a 0.00% change from fiscal 2021.
- Lipella Pharmaceuticals Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $5.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |||||
| 2024-12-31 | $6.16 10-Q · filed 2025-11-14 | |||||
| 2024-03-31 | $6.16 10-Q · filed 2024-11-14 | $0.77 10-Q · filed 2024-05-09 | ||||
| 2023-12-31 | $17.52 10-K · filed 2025-03-28 | $2.19 10-K · filed 2024-02-27 | ||||
| 2022-12-31 | $5.00 10-K · filed 2024-02-27 | |||||
| 2021-12-31 | $5.00 10-K · filed 2023-03-31 |